Australia Finds ‘Unacceptable’ Levels Of NDMA In 80% of Ranitidine Batches
Executive Summary
Testing carried out by Australia's drug agency on batches of 34 ranitidine products marketed by 10 different sponsors has found high levels of NDMA contamination in the vast majority of cases. The agency is now considering tightening its oversight of all ranitidine drugs sold in Australia.
You may also be interested in...
Australia Suspends 23 Ranitdine Products Contaminated with NDMA
A six-month suspension from sale has been handed to 23 ranitidine drugs sold in Australia. The country's regulator has suggested all 23 are facing a permanent ban over patient safety fears.
EU Guidance Assists With Nitrosamine Evaluations
The EU guide covers medicines authorized at the national level and under the mutual recognition and decentralized procedures.
EU Offers Practical Guide To Help Pharma With Nitrosamine Evaluations
The EU guide covers medicines authorized at the national level and under the mutual recognition and decentralized procedures.